1. Tiger snake antivenom, raised against Notechis scutatus venom, is indicated not only for the treatment of envenomation by this snake, but also that of the copperhead ( Austrelaps superbus ) and Stephen's banded snake ( Hoplocephalus stephensi ). The present study compared the neuromuscular pharmacology of venom from these snakes and the in vitro efficacy of tiger snake antivenom.
INTRODUCTION
Australia is home to a collection of the world's most venomous elapid snakes. Based on the clinical effects of envenomation and the type of monovalent antivenom required for treatment, it has been proposed that these snakes may be classified into five groups. 1 One such group includes tiger snakes, copperheads and banded/ broad-headed snakes because Commonwealth Serum Laboratories (CSL) tiger snake antivenom is indicated for the treatment of systemic envenomation by all these snakes. In fact, it has been suggested that the common (lowland) copperhead ( Austrelaps superbus ) is so closely related to the common tiger snake ( Notechis scutatus ) that it should be included in the Notechis genus. 2 In addition, tiger snake antivenom has been used to reverse coagulation anomalies in patients after envenomation by Stephen's banded snake ( Hoplocephalus stephensi ). 3 Although a considerable amount of research has been directed at the neurotoxic components of the venom from N. scutatus , [4] [5] [6] [7] [8] [9] [10] the venom of A. superbus has been understudied, except for the identification of some anticoagulant and antiplatelet activity. [11] [12] [13] While the venom of H. stephensi has been shown to display haemorrhagic and procoagulant activities, 14, 15 any neurotoxic components of this venom have been largely ignored. The present study compared the neuromuscular pharmacology of venom from these snakes and the efficacy of tiger snake antivenom against the in vitro neurotoxicity. In addition, the venoms were profiled using on-line liquid chromatography-mass spectrometry (LC-MS) to examine variations in venom composition.
METHODS

Chick biventer cervicis nerve-muscle preparation
Chicks (4-10 days old) were killed by CO 2 and exsanguination and the biventer cervicis muscles were removed and mounted in tissue baths (10 mL) under a resting tension of 1 g. Tissues were bathed in modified physiological salt solution (34 Њ C), bubbled with 95% O 2 and 5% CO 2 , of the following composition (in mmol/L): NaCl 118.4; NaHCO 3 For direct muscle stimulation (0.1 Hz, 2 msec and a voltage greater than that required to evoke a maximal twitch), neuromuscular transmission was abolished by the continuous presence of tubocurarine (10 mol/L) and the electrodes placed around the belly of the muscle.
Mouse phrenic nerve-diaphragm preparation
Hemidiaphragms were dissected from male mice (20-25 g ) and mounted in 10 mL organ baths containing physiological salt solution (as described above; 37 Њ C). The attached phrenic nerve was stimulated at a voltage greater than that required to evoke a maximal twitch (0.1 Hz, 0.2 msec).
Antivenom experiments
Where indicated, tiger snake antivenom (1 or 5 units/mL) was added 10 min prior 17, 17 to the addition of venoms (10 g/mL). Additional experiments were undertaken to examine the reversibility of the inhibitory effects of the venoms. In these experiments, tiger snake antivenom (5 units/mL) was added after the venoms had produced a 90% inhibition of nerve mediated twitches (i.e. at t 90 ). 17 Twitch height was then monitored for a further 3 h period.
Liquid chromatography-mass spectroscopy analysis
On-line LC-MS of venom samples dissolved in 0.1% trifluoroacetic acid (TFA) to a concentration of approximately 1 mg/mL was performed on a Vydac C18 analytical column (2.1 ϫ 250 mm, 5 m particle size, 300 Å; Alltech Associates, Sydney, NSW, Australia) with solvent A (0.05% TFA) and solvent B (90% acetonitrile in 0.045% TFA) at a flow rate of 130 L/ min. The solvent delivery and gradient formation of 0-90% acetonitrile/ 0.05% TFA over 90 min was achieved using an Applied Biosystems 140B solvent delivery system (Applied Biosystems, Scoresby, Victoria, Australia). Electrospray mass spectra were acquired on a PE-SCIEX III triple quadrupole mass spectrometer (MDS Sciex, Ontario, Canada) equipped with an ionspray ionization source. The electrospray Sprayer voltage was 5200 V, Orifice 120 V, Ring 280 V and the Skimmer 80 V. Samples (10 L) were injected manually into the LC-MS system and analysed in positive ion mode. Full scan data were acquired over the mass range 400-2100 Da with a step size of 0.2 amu. Data processing was performed with the aid of the software package Biomultiview (PE-SCIEX, Ontario, Canada).
Drugs
Acetylcholine chloride, carbamylcholine chloride (carbachol) and D -tubocurarine chloride were purchased from Sigma (St Louis, MO, USA). Freeze-dried venoms were purchased from Venom Supplies (Tanunda, SA, Australia). Pooled venoms from different snakes were used for all species to minimize the effects of individual variations. The same batch of venom was used for all studies. Stock solutions were prepared by dissolving the venoms in 0.1% bovine serum albumin (BSA) in saline (0.9% w/v). These were aliquoted and stored at -20 Њ C until required.
Statistics
Data were analysed using GraphPad Prism (GraphPad Software, San Diego, CA, USA) and SigmaStat (SPSS Science, Chicago, IL, USA). The t 90 values were compared by two-way ANOVA . Comparison of experiments where antivenom was added at t 90 was undertaken using a two-way repeatedmeasures ANOVA to compare differences between the three venoms at all time points. Post hoc pairwise multiple comparisons were performed using Bonferroni's method. Statistical significance was indicated when P < 0.05. All data are expressed as the mean ± SEM.
RESULTS
Effect of venoms on indirect twitches
Chick biventer cervicis preparation
All three venoms at 3 g/mL (Fig. 1a) and 10 g/mL (Fig. 1b) produced time-dependent block of indirect twitches in the chick biventer cervicis preparation with the following rank order of potency: N. scutatus ≥ H. stephensi > A. superbus ( Fig. 1; Table 1 ). There was a significant difference between the t 90 values for 
Data are the mean ± SEM with the number of experiments given in parentheses. * P < 0.05 compared with 3 g/mL of the corresponding venom (two-way ANOVA ); † P < 0.05 compared with N. scutatus venom at the corresponding concentration (two-way ANOVA ).
H. stephensi and A. superbus venoms at a concentration of 3 g/mL compared with 10 g/mL (P < 0.05; Table 1 ), indicative of a concentration-dependent inhibitory effect. However, there was no significant difference between the t90 values at concentrations of 3 and 10 g/mL for N. scutatus venom, indicating a near maximal effect at 3 g/mL in this preparation. All three venoms (10 g/mL) abolished contractile responses to exogenous ACh (1 mmol/L) and CCh (20 mol/L), but responses to KCl (40 mmol/L) were not significantly inhibited (i.e. 90 ± 13, 87 ± 4 and 100 ± 8% of initial response for N. scutatus, H. stephensi and A. superbus, respectively; P > 0.05 compared with time control).
Mouse diaphragm
All three venoms at 3 g/mL (Fig. 2a) and 10 g/mL (Fig. 2b) produced time-dependent block of indirect twitches in the mouse diaphragm preparation with the same rank order of potency displayed in the chick biventer (i.e. N. scutatus ≥ H. stephensi > A. superbus; Fig. 2 ; Table 1 ).
There was a significant difference between the t90 values for H. stephensi and A. superbus venoms at a concentration of 3 g/mL compared with 10 g/mL (P < 0.05; Table 1 ), indicative of a concentration-dependent inhibitory effect. However, there was no significant difference between the t90 values at concentrations of 3 and 10 g/mL for N. scutatus venom, indicating a near maximal effect at 3 g/mL in this preparation.
Efficacy of tiger snake antivenom
Pre-incubation of antivenom
Prior incubation (10 min) with 1 unit/mL tiger snake antivenom in the chick biventer cervicis preparation markedly attenuated the inhibitory effects of N. scutatus and A. superbus venoms (10 g/mL), but was relatively ineffective against the inhibitory effects of H. stephensi venom (10 g/mL; Fig. 3a) . However, prior incubation with 5 units/mL tiger snake antivenom abolished the inhibitory effects of all three venoms (10 g/mL; Fig. 3a) .
Antivenom added at t90
The addition of tiger snake antivenom (5 units/mL) at t90 significantly reversed, over a period of 3 h, the inhibition of twitches produced by 10 g/mL of all three venoms (i.e. 41 ± 6, 50 ± 4 and 25 ± 2% recovery for N. scutatus, H. stephensi and A. superbus, respectively; Fig. 3b ). There was no spontaneous recovery of twitches when venoms were left in contact with the preparation, in the absence of antivenom, for a period of 3 h (n = 4-6; data not shown).
Effect of venoms on direct twitches
Austrelaps superbus and N. scutatus venoms (10 g/mL) produced significant inhibition of direct twitches in the chick biventer cervicis preparation, indicative of myotoxicity (Fig. 4a) . However, H. stephensi venom had no significant effect at this concentration (Fig. 4a) . At a higher concentration (i.e. 100 g/mL), all three venoms produced marked inhibition of direct twitches (Fig. 4b) . In addition, all three venoms produced a slowly developing contractile response in this preparation (data not shown).
Liquid chromatography-mass spectrometry analysis of venoms
Venoms were profiled using LC-MS to determine differences in venom composition (Fig. 5) . All venoms were found to contain a number of components with molecular weights corresponding to post-synaptic (6-8 kDa) and presynaptic (12-14 kDa) neurotoxins. 18 A single peak with a molecular weight of 46 kDa (consistent with a subunit of a prothrombin activator 16 ) was evident in the N. scutatus and H. stephensi venoms, but not in the A. superbus venom. Evident in all three venoms were a number of compounds with molecular weights of 3-4 kDa, consistent with that of natriuretic peptides. 19 Also present in the H. stephensi and N. scutatus venoms were 23 kDa components with retention times consistent with cyclic nucleotide-gated ion channel-blocking toxins. 20 The venoms displayed only minimal homology to each other in regards to possessing compounds with the exact same retention time and molecular weight.
DISCUSSION
While there is little doubt that systemic envenomation by N. scutatus is associated with marked neurotoxicity, there is considerably less known regarding the nature of H. stephensi envenomation. 21 Unlike N. scutatus, H. stephensi are semi-arboreal and have a narrower range of distribution, 22 perhaps contributing to the low number of documented cases of envenomation by this species. Two recent reports on the clinical effects of envenomation by Hoplocephalus species documented rapidly developing severe hypotension and coagulation disturbances. No signs of neurotoxicity were evident. 3 The limited experimental studies performed on H. stephensi crude venom have focused on the presence of haemorrhagic and procoagulant activities, 14 as well as the lethality of the venom in whole animal studies. 23 It has been suggested that members of the genus Austrelaps rarely bite humans and that considerable provocation is required before they will strike in anger. 22 However, the effects of envenomation can be severe. One report detailed profound paralysis in a dog following a bite by this species. 22 Because the murine subcutaneous LD50 of this species is 0.5 mg/kg 24 and the venom yield is 26-85 mg, 22 this species should be considered capable of a lethal envenomation.
The results of the present study indicate that all three venoms studied contain post-synaptic neurotoxic activity, as evidenced by their inhibition of indirect twitches in both neuromuscular preparations and their selective inhibition of exogenous nicotinic receptor agonists. Although not consistent with the clinical effects of envenomation by some of the species, in particular H. stephensi, these results are supported by the LC-MS analysis of the venoms revealing components with molecular weights within the range of peptidic neurotoxins. These results enable us to make a comparison with the neurotoxic activity of venoms from some other Australian elapids that we have previously examined. 16, 17, 24, 25 The three venoms used in the present study were less potent, as determined by t90 values (mean ± SEM, in minutes; all obtained at a venom concentration of 10 g/mL), in the chick biventer cervicis preparation than Acanthophis antarcticus (14 ± 1) and Acanthophis pyrrhus (14 ± 1), equipotent with Acanthophis praelongus (19 ± 2) and Oxyuranus microlepidotus (27 ± 3), but considerably more potent than Oxyuranus scutellatus (42 ± 3) and Oxyuranus scutellatus canni (48 ± 5).
Interestingly, venom from the Papuan taipan (O. s. canni) was markedly more potent in the murine preparation (25 ± 1) compared with the avian preparation, whereas Acanthophis sp. venoms 18 and, in the present study, N. scutatus and H. stephensi venoms were approximately equipotent. Only the venom of A. superbus was less potent in the murine preparation. The reasons for these differences in sensitivity are unclear, but may be related to adaptive changes in and Austrelaps superbus (ᮀ) venoms at (a) 10 g/mL (n = 5-6) and (b) 100 g/mL (n = 4-6) on direct twitches of the chick isolated biventer cervicis nerve-muscle preparation.
venom composition due to prey preference. 26 However, the dietary preferences of these snakes suggest that this is unlikely: A. superbus, reptiles (63%) and frogs (35%); N. scutatus, frogs (92%) and mammals (4%); H. stephensi, mammals (45%), reptiles (44%) and frogs (11%). 27 In addition, the rank order of neurotoxicity of the venoms in the mouse diaphragm preparation (i.e. N. scutatus ≥ H. stephensi > A. superbus) is different than that reported for LD50 values in whole mice (s.c. in 0.1% BSA), where there were marked differences: N. scutatus (0.118 mg/kg) > A. superbus (0.5 mg/kg) > H. stephensi (1.44 mg/kg). 23 However, we have previously alluded to the limits of comparing these different techniques. 17 All venoms displayed myotoxicity in vitro as evidenced by their inhibitory effects on direct twitches and slowly developing contractile response in the chick biventer cervicis. 10 Hoplocephalus stephensi venom displayed the weakest myotoxicity, having no apparent effect at 10 g/mL and a slower onset of activity at 100 g/mL.
Despite the availability of a range of monovalent snake antivenoms in Australia targeted against a number of species (e.g. tiger snakes, taipans, death adders), quite a few snakes are not specifically covered. In these cases, antivenoms raised against other species are used. Therefore, tiger snake antivenom is recommended for envenomation by all species of Austrelaps and Hoplocephalus. 18 The results of the present study with tiger snake antivenom, either added prior to the venoms or after the venoms had produced considerable neuromuscular blockade, clearly show that the antivenom is effective against the in vitro neurotoxicity produced by all three venoms, supporting the current treatment recommendations. Tiger snake antivenom has been used previously to treat the coagulation abnormalities observed following H. stephensi envenomations. 3 Interestingly, in the present study, H. stephensi venom was relatively unaffected by the lower concentration of antivenom (i.e. 1 unit/mL added prior to venom), whereas the effects of N. scutatus and A. superbus were almost completely abolished. This may reflect differences in venom composition or in the quantities of individual components, which are neutralized by the antivenom, within the venoms.
This study provides further data regarding the potential effects of Australian elapids. While neurotoxicity has not been reported as a clinical feature of envenomation by H. stephensi, central to the clinical picture is profound hypotension followed by severe disruption of blood chemistry. These effects may be accounted for by the presence of putative natriuretic peptides and a prothrombinactivating enzyme 16 in the venom. Further work to isolate natriuretic peptides from this venom is underway. However, the current results indicate that neurotoxicity is potentially a complication of envenomation and that tiger snake antivenom may have a role in reversing these effects.
